Sangamo Therapeutics, Inc. (0R1D.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 115.97M |
| Enterprise Value | 121.82M |
| P/E Ratio | -0.46 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 2.1 |
| Price/Book Ratio | -3.6 |
| Enterprise/Revenue | 1.86 |
| Enterprise/EBITDA | -0.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.57 |
| Operating Margin | -3.19 |
AD
Management Effectiveness
| Return On Assets | -2.06 |
| Return On Equity | 66.86 |
Income Statement
| Revenue | 39.55M |
| Revenue/Share | 0.09 |
| Gross Profit | 31.95M |
| EBITDA | -100.4M |
| Net Income | -122.93M |
| Diluted EPS | -0.44 |
Balance Sheet
| Total Cash | 27.59M |
| Total Cash/Share | 0.07 |
| Total Debt | 19.33M |
| Total Debt/Equity | -1.02 |
| Current Ratio | 0.7 |
| Book Value Per Share | -0.05 |
Price History
| 52-Week Change | -58.72 |
| 52-Week High | 2.11 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.72 |
| Moving Average 200 Days | 0.81 |
Statistics
| Average Volume | 47,193 |
| Shares Outstanding | 411.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
